Fingerprint
Dive into the research topics of 'Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: Results from COMPARZ, a randomized controlled trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically